Sucralose DNA damage claims complicated by safety reviews and follow-up studies

In 2023, researchers at North Carolina State University and the University of North Carolina at Chapel Hill published findings that sent a tremor through the world of food safety: sucralose-6-acetate, a chemical relative of the artificial sweetener sucralose found in Splenda, damaged DNA in laboratory-cultured human cells and weakened the intestinal barrier in tissue models. The team, led by adjunct professor Susan Schiffman, had identified the compound as an impurity present in commercial sucralose samples at concentrations up to 0.67 percent. When they exposed human blood cells directly to sucralose-6-acetate, they observed patterns consistent with DNA strand breaks. In intestinal tissue experiments, both sucralose and sucralose-6-acetate increased permeability of the gut wall, damaging the tight junctions where cells connect. The researchers also found that exposure altered gene activity in intestinal cells, increasing activity in genes linked to oxidative stress, inflammation, and carcinogenicity. Schiffman warned at the time that trace amounts of sucralose-6-acetate in a single daily sweetened drink might exceed the European Food Safety Authority's threshold of toxicological concern for genotoxic substances—0.15 micrograms per person per day—and called for people to avoid sucralose products.

But the laboratory results, striking as they were, did not tell the whole story. The 2023 experiments took place in cells and tissue cultures outside a living organism, not in people consuming the sweetener. Exposing cultured cells directly to a chemical can reveal a potential hazard, but it does not establish whether eating food containing that chemical exposes human tissues to enough of it to cause the same damage. The research also built on earlier work from 2018 in which the team had found compounds in rat urine and feces that they interpreted as evidence sucralose was being chemically altered inside the animals. But the European Food Safety Authority, in its comprehensive 2026 reassessment, noted that those compounds could have been impurities already present in the administered sucralose rather than products of metabolism. Their appearance in waste therefore did not necessarily prove that the body had transformed sucralose into something harmful.

The question of whether sucralose-6-acetate actually forms during human digestion became central to evaluating the real-world risk. The 2023 team had found the compound in off-the-shelf sucralose before consumption, but the mechanism by which it might be produced in the body remained unclear. This distinction mattered enormously. A threshold of toxicological concern is a conservative screening tool used to flag chemicals needing closer assessment when detailed toxicity data is limited. Exceeding such a threshold is not the same as demonstrating that a drink causes disease. It is also different from the acceptable daily intake established specifically for sucralose—15 milligrams per kilogram of body weight per day—which regulators consider safe to consume daily over a lifetime.

In February 2026, the European Food Safety Authority published its full reassessment. The panel considered the 2023 research directly, including the reported DNA damage signals and concerns about sucralose-6-acetate, but judged the laboratory screening evidence to have limited relevance for determining real-world safety. After weighing laboratory, animal, and other evidence, the experts concluded that sucralose's use as a food additive did not raise a genotoxicity concern. They retained the acceptable daily intake and found that estimated dietary exposure across population groups remained below that level. In the United States, the Food and Drug Administration also kept sucralose approved, noting that its safety assessment had included more than 110 studies addressing potential toxic effects, along with human clinical research.

That same year, another genetic toxicity study added complexity to the picture. Published in August 2026 in Food and Chemical Toxicology, the research tested commercial-grade sucralose using several genetic toxicity tests in cells and animals. The authors reported negative results in most assays, including tests for mutations and chromosome damage. A study in genetically modified mice found no increase in the mutations being measured. One test, a comet assay, did detect DNA damage signals in several tissues, but the authors described complications in interpreting those results and concluded that the overall findings did not indicate genotoxicity. The study's industry connections—several authors were affiliated with Tate & Lyle, a major sweetener manufacturer, while others worked for Intertek—warranted noting as context. Importantly, this investigation tested commercial sucralose rather than directly repeating the 2023 experiments with isolated sucralose-6-acetate, so the two studies addressed related but not identical questions.

Meanwhile, separate research explored other ways sucralose might affect the body. A randomized study published in Nature Metabolism in March 2025 found that when 75 young adults consumed drinks sweetened with sucralose, compared with sugar, the sweetener increased reported hunger and blood flow in the hypothalamus, the brain region involved in appetite regulation. Compared with water alone, sucralose increased hypothalamic blood flow but did not change hunger ratings. These were immediate responses, not evidence of lasting metabolic harm. A systematic review published in August 2026 examined 23 randomized trials of sucralose and cardiometabolic outcomes in healthy adults. Results for blood sugar regulation were mixed: some studies reported unfavorable changes, while others found no effect. The review's authors raised concerns about possible metabolic effects, underscoring that questions about appetite and glucose regulation remained distinct from the original claim about DNA damage.

The European review also identified an unresolved issue involving what happens when sucralose is heated. Under certain high-temperature conditions, chlorine from sucralose may become incorporated into other compounds whose health effects remain uncertain. For that reason, the panel could not confirm the safety of a proposed expansion of sucralose use in certain baked goods. It also noted that similar uncertainties can arise during baking or frying at home, where temperatures, cooking times, and amounts vary. This concern involved products that might form during heating rather than a confirmation of the 2023 sucralose-6-acetate findings.

Taken together, the evidence supports a more specific conclusion than a blanket warning about DNA damage. The 2023 study reported potentially important effects in laboratory systems, while subsequent assessments have not established that ordinary sucralose consumption causes the same harm in people. Questions about particular compounds, exposure conditions, and other biological effects remain areas for investigation. The story is not one of a dangerous sweetener being covered up, nor of a false alarm entirely debunked. It is one of laboratory findings that raised legitimate questions, followed by regulatory scrutiny that found the questions did not translate into demonstrated risk at approved consumption levels—while acknowledging that some uncertainties, particularly around heating and appetite effects, warrant continued attention.